Work

63764 Clinical Trial Evidence Supporting Approval of Novel Dermatologic Therapeutic Agents by the US Food and Drug Administration, 2014-2023

Year: 2025

Type: article

Source: Journal of the American Academy of Dermatology

DOI: 10.1016/j.jaad.2025.05.596

Authors: Samir Kamat, Benjamin Ungar, Ross O’Hagan, Joy Wan, MSCE, Joseph Ross, Ravi Gupta, MSHP

Institutions: Icahn School of Medicine at Mount Sinai, Johns Hopkins University, Johns Hopkins Medicine, Yale University

Language: English

Topic: Pharmaceutical industry and healthcare

Subfield: Issues, ethics and legal aspects

Field: Nursing

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4413871504

FWCI:

Cites:

Cited by:

Related to: 10